Skip to main content

Want a detailed portfolio tracker?

TuHURA Biosciences (HURA) P/E (2021 - 2026)

TuHURA Biosciences (HURA) P/E from Mar 31, 2021 to Jul 21, 2026. The TTM TuHURA Biosciences (HURA) P/E is -3.93. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of TuHURA Biosciences (HURA)

YearP/EChange
2026-3.93+209.67%
2025-1.27-55.58%
2024-2.86+710.91%
2023-0.35-97.95%
2022-17.21-72.98%
2021-63.71N/A

Comparison TuHURA Biosciences (HURA) P/E with competitors

TuHURA Biosciences (HURA) P/E is -3.93.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.04%
NBYStablecoin Development Corp0.00-100.11%
ENLVEnlivex Ltd0.07-101.90%
FGENFibroGen Inc0.24-106.10%
CHRSCoherus Biosciences Inc0.85-121.57%
FBIOFortress Biotech Inc0.95-124.12%
ORMPOramed Pharmaceuticals Inc1.50-138.21%
AGENAgenus Inc3.01-176.50%
INVAInnoviva Inc3.15-180.17%
VXRTVaxart Inc3.55-190.23%
CRMDCorMedix Inc3.63-192.23%
CVACCureVac N.V.4.45-213.00%
GLPGGalapagos NV4.86-223.51%
SRPTSarepta Therapeutics Inc4.88-224.10%
ABEOAbeona Therapeutics Inc5.39-236.94%
ABUSArbutus Biopharma Corp5.60-242.23%
ZVRAZevra Therapeutics Inc5.89-249.65%
SPROSpero Therapeutics Inc6.23-258.32%
CGENCompugen Ltd6.31-260.49%
RIGLRigel Pharmaceuticals6.87-274.68%
SLXNSilexion Therapeutics Corp7.30-285.46%
OMEROmeros Corporation9.26-335.34%
AUPHAurinia Pharmaceuticals Inc9.58-343.64%
PLXProtalix BioTherapeutics Inc10.89-376.83%
ACADAcadia Pharmaceuticals Inc11.73-398.12%
TBPHTheravance Biopharma Inc12.26-411.69%
ADMAAdma Biologics Inc12.42-415.65%
HRMYHarmony Biosciences Holdings Inc13.82-451.29%
SABSSAB Biotherapeutics Inc14.14-459.32%
NAGENiagen Bioscience Inc14.82-476.66%
INCYIncyte Corp15.82-502.19%
REGNRegeneron Pharmaceuticals Inc15.86-503.06%
PBYIPuma Biotechnology Inc17.32-540.14%
CPRXCatalyst Pharmaceuticals Inc17.44-543.28%
EXELExelixis Inc17.54-545.79%
TGTXTG Therapeutics Inc18.97-582.09%
MDXGMimedx Group Inc20.55-622.42%
XOMAXOMA Royalty Corp22.87-681.46%
ARGXArgen X SE24.30-717.64%
CTMXCytomX Therapeutics Inc24.82-730.94%
XOMAOXOMA Royalty Corp25.34-744.25%
HALOHalozyme Therapeutics Inc25.62-751.34%
XOMAPXOMA Royalty Corp25.67-752.52%
VRTXVertex Pharmaceuticals Inc27.99-811.61%
RPRXRoyalty Pharma plc - Class A28.69-829.22%
SLNOSoleno Therapeutics Inc29.02-837.55%
ASNDAscendis Pharma A/S30.09-864.76%
LGNDLigand Pharmaceuticals Inc - Class B37.91-1063.70%
APLSApellis Pharmaceuticals Inc39.02-1091.89%
BMRNBiomarin Pharmaceutical Inc42.21-1173.00%
KRYSKrystal Biotech Inc45.34-1252.60%
ONCBeiGene Ltd69.54-1867.67%
PHARPharming Group N.V.75.03-2007.10%
TECHBio-Techne Corp101.96-2691.72%
VCELVericel Corp109.92-2894.13%
ALNYAlnylam Pharmaceuticals Inc117.96-3098.60%
GMABGenmab140.29-3666.10%
TLXTelix Pharmaceuticals Ltd162.15-4221.83%
CORTCorcept Therapeutics Inc212.86-5510.71%